Haohui Fang

Aumolertinib as adjuvant therapy in resected EGFR-mutated non-small-cell lung cancer (ARTS): a double-blind, multicen...

Perioperatieve toripalimab plus chemotherapie bij resectabel NSCLC: Neotorch fase III